SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as community members express bullish sentiment and anticipate a breakout, particularly around the $200 mark. Discussions also involve various Solana-based meme coins like $WAGMI and $SOLYCAT, reflecting interest in the Solana ecosystem. Some traders are eyeing potential short squeezes and retesting of resistance levels.

Trump For President

TRUMP CRYPTO is seeing active discussion driven by community speculation on its long-term potential and mentions of potential partnerships. While some investors express bullish sentiment and compare it to other meme coins, others criticize it as a "scam coin" and point to its significant price decline since inception. The coin is also being discussed in the context of broader political opinions and the performance of other Trump-related assets.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending amid buyout speculation, particularly involving Novartis, following reports of a potential acquisition approach. The community is actively discussing the possibility of a deal, with some anticipating a significant premium, while others focus on upcoming data readouts and analyst target bumps. The company's strong uptrend after trial optimism and consistent institutional interest are also key talking points.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its community rallies around the revival of OG memes and a return to the culture's roots. Community members express excitement and a shared belief in the project, emphasizing its strong community and organic growth. The broader discussion revolves around making memes great again and the power of community-driven projects.

Shibmas was launched on the 9th Of December. The project is a meme token and gives homage to Shiba Inu the token. The token is a playful character who is bringing the Christmas spirit to token holders all around the world. We plan on getting many listings on various exchanges in the coming days. We have over 1000 holders in 24 hours and we aim on getting over 10000 holders within the next week and in the run up to Christmas

Shibmas

Shibmas ($SMAS) is gaining attention, particularly within the Phantom Wallet community, as traders discuss its potential for a breakout. Bullish sentiment is fueled by perceived positive chart patterns and strong momentum, with many highlighting its potential for rapid gains. The crypto is currently testing resistance levels, leading to increased monitoring of volume.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses its adoption by Kalshi and potential for significant growth in the RWA (Real World Asset) space. Talk centers on its role in providing real-time data and the potential impact of institutional investment. Some users are comparing it to Chainlink and anticipating a price surge.

CryingNTheCasino

CryingNTheCasino ($TEARY) is trending due to its focus on community building and a strong 'HODL' mentality, with the community emphasizing its power and shared belief in the project. The project's development team is comprised of OGs, which is contributing to positive sentiment.

Just a dead guy

DEADGUY, a meme coin, is gaining traction as community members highlight its potential for a 'stealth relaunch' and are actively sharing the contract address. The coin's rising holder count and perceived strong community energy are key discussion points. Some are drawing comparisons to other meme coins, speculating on significant market cap growth.

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis AG - ADR

Novartis AG

Novartis is trending due to positive developments and strategic moves, including strong Phase III results for Fabhalta in kidney disease, setting the stage for potential FDA approval, and promising data for Scemblix in leukemia. The community is discussing Novartis' potential growth strategy and pipeline, as well as potential acquisitions and partnerships in the radiopharmaceutical and AI spaces. Analysts note the company's solid financials and key catalysts, although some express concerns about Cosentyx and future earnings.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

TER is trending as investors assess its potential amid mixed analyst ratings and upcoming earnings, with discussions focusing on AI compute demand and the impact of robotics performance. The community is also closely watching unusual options activity and recent price target adjustments, weighing both bullish and bearish signals. Broader sector strength in semiconductors and potential strategic positioning are contributing to the ongoing conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.

Synergy Pharmaceuticals Incorporated

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Current Price	$0.0064
Prev Close	$0.0067
Open	$0.007
Dividend Yield	N/A
50-Day Moving Average	$0.0438
Beta	2.75
Avg. Volume	2.02M
PE Ratio	N/A

52-Week High	$2.10
52-Week Low	$0.005
Market Capitalization	$1.59M
EPS (Annual)	N/A
Price to Book	-0.02
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

SGYP
Synergy Pharmaceuticals, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest SGYP News

SGYPSynergy Pharmaceuticals, Inc.